Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy2018-01-17T17:06:02-05:00
Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS Cholesterol-lowering statins possess anti-inflammatory activity that might be useful for treatment of MS2018-01-17T17:05:43-05:00
Interferon beta in multiple sclerosis: how much BENEFIT? Interferon beta in multiple sclerosis: how much BENEFIT?2018-01-17T17:05:43-05:00
Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis Not Every Patient With Multiple Sclerosis Should Be Treated at Time of Diagnosis2018-01-17T17:05:43-05:00
Is nalalizumab a breakthrough in the treatment of MS? Is nalalizumab a breakthrough in the treatment of MS?2018-01-17T17:05:43-05:00
Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol Immune Modulation in Multiple Sclerosis Patients Treated with the Pregnancy Hormone Estriol2018-01-17T17:05:35-05:00
Silencing Autoimmunity in Multiple Sclerosis, Lupus, and Rheumatoid Arthritis Silencing Autoimmunity in Multiple Sclerosis, Lupus, and Rheumatoid Arthritis2018-01-17T17:05:35-05:00
Growth factor treatment of demyelinating disease: at last, a leap into the light Growth factor treatment of demyelinating disease: at last, a leap into the light2018-01-17T17:05:11-05:00
New directions in MS therapeutics: vehicles of hope New directions in MS therapeutics: vehicles of hope2018-01-17T17:05:11-05:00
Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis2018-01-17T17:05:05-05:00
